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INFECTIOUS MONONUCLEOSIS. Edited by R. L. Carter and H. G. Penman.
Oxford and Edinburgh, Blackwell Scientific Publications; Philadelphia,
F. A. Davis Co., 1969. 258 pp. $12.00.
In his foreword to this volume, Dr. Paul Beeson points out that "the
disease certainly justifies prodigious study, as it may well be the model
which will provide important clues to links between immune phenomena,
virus infections and neoplastic diseases." In this book, thirteen distin-
guished contributors have provided a comprehensive review of both clinical
and experimental observations as well as a critical evaluation of recent
findings in infectious mononucleosis.
A careful recording by the editors of the early history of mononucleosis
does much to dispel a number of inconsistencies and contradictions that
prevail in the extensive literature of this disorder. The spirited controversy
surrounding Pfeiffer's description of Driisenfieber is put in perspective as
is the long-lasting confusion that has resulted from the indiscriminate use
of the terms, infectious mononucleosis and glandular fever.
The chapters devoted to clinical features and hematologic changes are
particularly complete and well documented; it is clear, however, that a
major problem that plagues much of the literature has been the lack of a
generally accepted definition of this disorder.
Detailed attention is given here to experimental studies of atypical
lymphocytes and to general observations of heterophile antibody systems.
Another chapter provides a lucid summary of the clinical serology of in-
fectious mononucleosis. One contributor, the late Dr. William Dameshek,
speculates on the nature of this disorder as a self-limited leukemic disease
and immunoproliferative disorder and raises any number of pertinent
and valuable questions.
The recent observations on the relationships between EB virus and
infectious mononucleosis have been included in an extensive appendix.
These are sharply focussed in relation to each of the preceding chapters
and current literature is thoroughly covered.
All in all, this monograph is an authoritative reference work of very
high quality and is a valuable and very timely book.
JAMES C. NIEDERMAN
SAFEGUARDING THE PUBLIC. Historical Aspects of Medicinal Drug Con-
trol. Edited by John B. Blake. Baltimore, The Johns Hopkins Press, 1970.
20 pp. $7.50.
Historical perspective is provided here on economic and ethical problems
concerning medicinal drugs. Twenty-five participants, besides the skillful
editor, were sponsored in a two-day conference by the National Library
of Medicine and the Josiah Macy, Jr. Foundation. Special consideration
was given to controls of the purity, quality, safety, and efficacy of drugs
prescribed by physicians, rather than to problems relating to quackery,
narcotics control, and price control.
The development of drug control in Britain between World War I and
the Medicines Bill of 1968 is an enlightening story. Among other provi-
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sions of the new bill, the British Pharmacopaeia Commission and its
laboratories will be taken over by the Ministry of Health, and many clauses
about the legal control and sale of drugs "will give Great Britain its first
really comprehensive legislation on medicines, and will give the public
the best possible protection in the light of modern knowledge."
In a survey of drug therapy before 1900, the distinguished author from
Zurich observes that controlled clinical trials and pharmacological ex-
perimentation grew up in the 18th century, but did not affect authorities
on materia medica like Cullen and Arnermann. In the early 19th century,
John Stuart Mill's work gave much philosophy of experience. The founder
of experimental pharmacology, Francois Magendie, was followed by
Claude Bernard, Buchheim, and others, we are reminded. It was observed
that the historians can describe the growth of critical acumen over parti-
ular time spans and contexts, while the active investigater, not a historian,
can analyze his own critical methodology and the concepts behind it. And
what of the so-called creed that "science progresses by successful approxi-
mations to the truth"?
And what of the A.M.A. goals set in the Progressive Era "that were
far beyond its reach"? "Actually, the A.M.A. was near the dawn of a
brighter era. Its own Council and Chemical Laboratory were to regulate
the manufacture of American synthetic drugs after the United States
entered the war, and within a few years there would be major break-
throughs in drug research." Later in the discussion:
On the other hand, the consumers of drugs have few champions,
and those it has are sometimes better intentioned than informed. Who
can look out better for the consumers' interest in the area of drugs
than the physician who is knowledgeable about drugs from his
training, who sees the needs of the consumer every time he treats
a patient? One of the great physicians of the 19th century, Rudolph
Virchow, said that the physician is the natural advocate of the poor.
Surely he is the natural advocate for all consumers of drugs, rich
or poor.
It is noted that in the early 1930's drug control seemed essentially a
problem of how best to protect the public against quacks. Another objec-
tive was to provide against the sale of drugs that were "dangerous" as
used, and to require that the drugs' labeling contain proper directions for
use. Introduction of the sulfonamides was a development of importance
in the evolution of drug control. Later, in evaluating drug regulation
under the 1938 act, and the F.D.A.'s responsibilities, many factors of
cause and effect are discussed. Considering the drug industry, the med-
ical profession, and the public, a basic theme is the medical communi-
cation problem. In partial summary, "How do we best keep doctors up
to date on therapeutic matters? How can we negatively reinforce bad
therapeutics, and positively reinforce exemplary therapeutics?" Some-
one has asked if there is a crisis spiral in health care and public health.
This relatively small volume contains a wealth of information, opinion,
and material for reflection toward future action.
IRA VAUGHAN HISCOCK
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